We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
+1.45%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
AUM
$559M
AUM Growth
-$42.7M
Cap. Flow
-$45M
Cap. Flow %
-8.06%
Top 10 Hldgs %
40.06%
Holding
82
New
3
Increased
3
Reduced
62
Closed
2

Top Sells

Rank Stock Value
1
CPHD
Cepheid Inc
CPHD
+$12.1M
2
WSM icon
Williams-Sonoma
WSM
+$3.85M
3
WFC icon
Wells Fargo
WFC
+$3.25M
4
CGNX icon
Cognex
CGNX
+$2.74M
5
GWW icon
W.W. Grainger
GWW
+$1.56M

Sector Composition

Rank Sector Weight
1 Healthcare 40.41%
2 Industrials 13.52%
3 Technology 12.19%
4 Consumer Discretionary 9.28%
5 Consumer Staples 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGNX icon
1
Cognex
CGNX
$10.5B
$28.4M 5.08%
892,120
-95,790
-10% -$2.74M
TIF
2
DELISTED
Tiffany & Co.
TIF
$27.6M 4.94%
356,596
-14,350
-4% -$1.11M
ADI icon
3
Analog Devices
ADI
$176B
$23.2M 4.16%
319,951
-13,200
-4% -$897K
JNJ icon
4
Johnson & Johnson
JNJ
$663B
$23.2M 4.16%
201,666
-5,240
-3% -$605K
NEOG icon
5
Neogen
NEOG
$2.58B
$22.7M 4.07%
918,104
-52,360
-5% -$1.16M
BIIB icon
6
Biogen
BIIB
$32.6B
$21.9M 3.92%
77,255
-4,655
-6% -$1.38M
BF.B icon
7
Brown-Forman Class B
BF.B
$12.3B
$19.8M 3.54%
687,411
-29,381
-4% -$859K
IDXX icon
8
Idexx Laboratories
IDXX
$42.2B
$19.5M 3.48%
165,940
-6,695
-4% -$764K
RTN
9
DELISTED
Raytheon Company
RTN
$18.9M 3.38%
132,897
-4,685
-3% -$666K
HON icon
10
Honeywell
HON
$66.4B
$18.6M 3.33%
177,697
-4,642
-3% -$472K
DHR icon
11
Danaher
DHR
$146B
$18.5M 3.3%
267,467
-12,887
-5% -$895K
DXCM icon
12
DexCom
DXCM
$33.2B
$15.7M 2.8%
1,049,080
-37,000
-3% -$655K
SLB icon
13
SLB Ltd
SLB
$85.3B
$15.2M 2.72%
181,032
-11,225
-6% -$920K
MA icon
14
Mastercard
MA
$507B
$15.1M 2.7%
146,155
-8,770
-6% -$908K
HSIC icon
15
Henry Schein
HSIC
$10B
$14.8M 2.65%
248,737
-9,920
-4% -$599K
NVO
16
Novo Nordisk
NVO
$206B
$14.4M 2.57%
800,790
+18,850
+2% +$342K
GWW icon
17
W.W. Grainger
GWW
$62.4B
$12.9M 2.31%
55,577
-7,015
-11% -$1.56M
AMGN icon
18
Amgen
AMGN
$236B
$12.1M 2.16%
82,432
-2,785
-3% -$419K
PODD icon
19
Insulet
PODD
$10.2B
$11.3M 2.03%
300,725
-15,500
-5% -$577K
INGN icon
20
Inogen
INGN
$144M
$11.1M 1.99%
165,200
-8,950
-5% -$552K
ROST icon
21
Ross Stores
ROST
$73.7B
$11M 1.97%
167,760
-3,230
-2% -$211K
XRAY icon
22
Dentsply Sirona
XRAY
$2.27B
$9.84M 1.76%
170,475
-1,421
-0.8% -$83.9K
GE icon
23
GE Aerospace
GE
$350B
$9.08M 1.63%
59,935
-1,649
-3% -$240K
ABMD
24
DELISTED
Abiomed Inc
ABMD
$9.06M 1.62%
80,415
-2,010
-2% -$233K
MTD icon
25
Mettler-Toledo International
MTD
$27B
$8.84M 1.58%
21,110
-1,425
-6% -$593K

Similar funds

Tirschwell & Loewy's Q4 2016 Portfolio in Review

As of Q4 2016, Tirschwell & Loewy held 82 positions worth $559M, down 7.1% from $601M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Tirschwell & Loewy withdrew a net $45M in Q4 2016, closing 2 positions and reducing 62 holdings. Its most notable exit was Cepheid Inc, an estimated $12.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 43% a quarter earlier, followed by Industrials and Technology.

Against the trend, Tirschwell & Loewy opened a new position in Starbucks worth $3.54M.

  • Tirschwell & Loewy's largest Q4 2016 buy was Starbucks: 63,850 shares worth $3.54M.
  • Tirschwell & Loewy added most to Novo Nordisk in Q4 2016, an estimated $342K increase.
  • Tirschwell & Loewy's biggest Q4 2016 reduction was Williams-Sonoma, cutting an estimated $3.85M.
  • Tirschwell & Loewy fully exited Cepheid Inc in Q4 2016, selling an estimated $12.1M.
  • Tirschwell & Loewy's ten largest holdings make up 40% of its $559M portfolio in Q4 2016.
  • Tirschwell & Loewy opened 3 new positions and closed 2 in Q4 2016.
  • Tirschwell & Loewy's portfolio value fell 7.1% quarter-over-quarter to $559M.

Based on Tirschwell & Loewy's 13F filing for Q4 2016, filed 3 Feb 2017.